Utah Medical Products, Inc.
UTMD
$64.51
-$0.48-0.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -10.18% | -1.23% | -1.93% | -4.30% | -14.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.18% | -1.23% | -1.93% | -4.30% | -14.37% |
| Cost of Revenue | -17.55% | -1.41% | 0.12% | 5.09% | -8.79% |
| Gross Profit | -4.62% | -1.11% | -3.41% | -10.52% | -18.15% |
| SG&A Expenses | 10.81% | 15.40% | 30.04% | 3.06% | 2.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.41% | 5.69% | 9.01% | 2.37% | -6.93% |
| Operating Income | -13.35% | -13.71% | -20.13% | -14.66% | -25.14% |
| Income Before Tax | -17.52% | -14.06% | -20.82% | -8.91% | -19.59% |
| Income Tax Expenses | -29.25% | -24.16% | 10.06% | 3.96% | -2.97% |
| Earnings from Continuing Operations | -14.37% | -11.58% | -26.16% | -11.73% | -23.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.37% | -11.58% | -26.16% | -11.73% | -23.13% |
| EBIT | -13.35% | -13.71% | -20.13% | -14.66% | -25.14% |
| EBITDA | -11.94% | -10.54% | -16.28% | -11.23% | -21.21% |
| EPS Basic | -11.00% | -6.32% | -19.93% | -3.97% | -15.98% |
| Normalized Basic EPS | -9.80% | -6.57% | -12.68% | -7.59% | -17.79% |
| EPS Diluted | -11.00% | -6.40% | -19.96% | -3.97% | -15.95% |
| Normalized Diluted EPS | -9.80% | -6.57% | -12.68% | -7.59% | -17.78% |
| Average Basic Shares Outstanding | -3.78% | -5.62% | -7.77% | -8.09% | -8.51% |
| Average Diluted Shares Outstanding | -3.78% | -5.62% | -7.77% | -8.09% | -8.52% |
| Dividend Per Share | 1.64% | 1.64% | 1.67% | 1.67% | 1.67% |
| Payout Ratio | 0.14% | 0.06% | 0.27% | 0.05% | 0.21% |